Rescue of a recombinant Machupo virus from cloned cDNAs and in vivo characterization in interferon (αβ/γ) receptor double knockout mice

Journal of Virology

Volumn 88, Issue 4, 2014, Pages 1914-1923

  Patterson, Michael ^a   Seregin, Alexey ^a   Huang, Cheng ^a   Kolokoltsova, Olga ^a   Smith, Jennifer ^a   Miller, Milagros ^a   Smith, Jeanon ^a   Yun, Nadezhda ^a   Poussard, Allison ^a   Grant, Ashley ^a   Tigabu, Bersabeh ^a   Walker, Aida ^a   Paessler, Slobodan ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYSIS OF VARIANCE; ANIMALS; ARENAVIRUSES, NEW WORLD; BASE SEQUENCE; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; DISEASE MODELS, ANIMAL; DNA PRIMERS; DNA, COMPLEMENTARY; HEMORRHAGIC FEVER, AMERICAN; HISTOLOGICAL TECHNIQUES; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PLASMIDS; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; REVERSE GENETICS; SEQUENCE ANALYSIS, RNA; VERO CELLS;

EID: 84893497309     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02925-13     Document Type: Article

References (58)

1. Beyer WR, Pöpplau D, Garten W, von Laer D, Lenz O. 2003. Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P. J. Virol. 77:2866-2872. http://dx.doi.org/10.1128/JVI.77.5.2866-2872.2003.
2. York J, Romanowski V, Lu M, Nunberg JH. 2004. The signal peptide of the Junin arenavirus envelope glycoprotein is myristoylated and forms an essential subunit of the mature G1-G2 complex. J. Virol. 78:10783-10792. http://dx.doi.org/10.1128/JVI.78.19.10783-10792.2004.
3. Eichler R, Lenz O, Strecker T, Eickmann M, Klenk H-D, Garten W. 2003. Identification of Lassa virus glycoprotein signal peptide as a transacting maturation factor. EMBO Rep. 4:1084-1088. http://dx.doi.org/10.1038/sj.embor.7400002.
4. York J, Nunberg JH. 2006. Role of the stable signal peptide of Junin arenavirus envelope glycoprotein in pH-dependent membrane fusion. J. Virol. 80:7775-7780. http://dx.doi.org/10.1128/JVI.00642-06.
5. Strecker T, Eichler R, Meulen Jt, Weissenhorn W, Dieter Klenk H, Garten W, Lenz O. 2003. Lassa virus Z protein is a matrix protein sufficient for the release of virus-like particles. J. Virol. 77:10700-10705. http://dx.doi.org/10.1128/JVI.77.19.10700-10705.2003.
6. Meyer BJ, Southern PJ. 1994. Sequence heterogeneity in the termini of lymphocytic choriomeningitis virus genomic and antigenomic RNAs. J. Virol. 68:7659-7664.
7. Tortorici MA, Albarino CG, Posik DM, Ghiringhelli PD, Lozano ME, Rivera Pomar R, Romanowski V. 2001. Arenavirus nucleocapsid protein displays a transcriptional antitermination activity in vivo. Virus Res. 73: 41-55. http://dx.doi.org/10.1016/S0168-1702(00)00222-7.
8. Mackenzie RB, Beye HK, Valverde L, Garron H. 1964. Epidemic hemorrhagic fever in Bolivia. I. A preliminary report of the epidemiologic and clinical findings in a new epidemic area in South America. Am. J. Trop. Med. Hyg. 13:620-625.
9. Webb PA. 1965. Properties of Machupo virus. Am. J. Trop. Med. Hyg. 14:799-802.
10. Johnson KM, Wiebenga NH, Mackenzie RB, Kuns ML, Tauraso NM, Shelokov A, Webb PA, Justines G, Beye HK. 1965. Virus isolations from human cases of hemorrhagic fever in Bolivia. Proc. Soc. Exp. Biol. Med. (New York, NY) 118:113-118. http://dx.doi.org/10.3181/00379727-118-29772.
11. Kuns ML. 1965. Epidemiology of Machupo virus infection. Am. J. Trop. Med. Hyg. 14:813-816.
12. Delgado S, Erickson BR, Agudo R, Blair PJ, Vallejo E, Albariño CG, Vargas J, Comer JA, Rollin PE, Ksiazek TG, Olson JG, Nichol ST. 2008. Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog. 4:e1000047. http://dx.doi.org/10.1371/journal.ppat.1000047.
13. Peters CJ. 2002. Human infection with arenaviruses in the Americas. Curr. Top. Microbiol. Immunol. 262:65-74.
14. Harrison LH, Halsey NA, McKee KT, Jr, Peters CJ, Barrera Oro JG, Briggiler AM, Feuillade MR, Maiztegui JI. 1999. Clinical case definitions for Argentine hemorrhagic fever. Clin. Infect. Dis. 28:1091-1094. http://dx.doi.org/10.1086/514749.
15. Weissenbacher MC, Laguens RP, Coto CE. 1987. Argentine hemorrhagic fever. Curr. Top. Microbiol. Immunol. 134:79-116.
16. Stinebaugh BJ, Schloeder FX, Johnson KM, Mackenzie RB, Entwisle G, De Alba E. 1966. Bolivian hemorrhagic fever: a report of four cases. Am. J. Med. 40:217-230. http://dx.doi.org/10.1016/0002-9343(66)90103-3.
17. Kilgore PE, Peters CJ, Mills JN, Rollin PE, LA, Khan AS, Ksiazek TG. 1995. Prospects for the control of Bolivian hemorrhagic fever. Emerg. Infect. Dis. 1:97-100. http://dx.doi.org/10.3201/eid0103.950308.
18. Webb PA, Johnson KM, Mackenzie RB, Kuns ML. 1967. Some characteristics of Machupo virus, causative agent of Bolivian hemorrhagic fever. Am. J. Trop. Med. Hyg. 16:531-538.
19. Child PL, MacKenzie RB, Valverde LR, Johnson KM. 1967. Bolivian hemorrhagic fever. A pathologic description. Arch. Pathol. 83:434-445.
20. Johnson KM, Kuns ML, Mackenzie RB, Webb PA, Yunker CE. 1966. Isolation of Machupo virus from wild rodent Calomys callosus. Am. J. Trop. Med. Hyg. 15:103-106.
21. Kilgore PE, Ksiazek TG, Rollin PE, Mills JN, Villagra MR, Montenegro MJ, Costales MA, Paredes LC, Peters CJ. 1997. Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin. Infect. Dis. 24:718-722. http://dx.doi.org/10.1093/clind/24.4.718.
22. Peters CJ, Kuehne RW, Mercado RR, Le Bow RH, Spertzel RO, Webb PA. 1974. Hemorrhagic fever in Cochabamba, Bolivia, 1971. Am. J. Epidemiol. 99:425-433.
23. Aguilar PV, Camargo W, Vargas J, Guevara C, Roca Y, Felices V, Laguna-Torres A, Tesh R, Ksiazek TG, Kochel TJ. September 2009, posting date. Reemergence of Bolivian hemorrhagic fever, 2007-2008. (Letter.) http://dx.doi.org/10.3201/eid159.090017.
24. ProMED-email. 2013. Bolivian hemorrhagic fever-Bolivia: (BENI). ProMED-email 20130317.1590121. http://www.promedmail.org/direct.php?id=20130317.1590121.
25. ProMED-email. 2013. Bolivian hemorrhagic fever-Bolivia (02): (BE). ProMED-email 20130420.1660132. http://www.promedmail.org/direct.php?id=20130420.1660132.
26. ProMED-email. 2012. Bolivian hemorrhagic fever-Bolivia (05): (BENI). ProMED-email 20120730.1220842. http://www.promedmail.org/direct.php?id=20120730.1220842.
27. ProMED-email. 2011. Bolivian hemorrhagic fever-Bolivia: (BE). ProMED-email 20111202.3514. http://www.promedmail.org/direct.php?id=20111202.3514.
28. Buchmeier M, de la Torre J, Peters C. 2007. Arenaviridae: the viruses and their replication, p 1791-1827. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
29. Eddy G, Wagner F, Scott S, Mahlandt B. 1975. Protection of monkeys against Machupo virus by the passive administration of Bolivian haemorrhagic fever immunoglobulin (human origin). Bull. World Health Organ. 52:723-727.
30. Stephen EL, Scott SK, Eddy GA, Levy HB. 1977. Effect of interferon on togavirus and arenavirus infections of animals. Texas Rep. Biol. Med. 35: 449-454.
31. Jahrling P, Trotter R, Barrero O. 1988. Cross protection against Machupo with candid #1 Junin virus vaccine. Oral presentation. Proceedings of the Second International Conference on the Impact of Viral Diseases on the Development of Latin American Countries and the Caribbean Region. Mar del Plata, Argentina.
32. Maiztegui JI, McKee KT, Jr, Barrera Oro JG, Harrison LH, Gibbs PH, Feuillade MR, Enria DA, Briggiler AM, Levis SC, Ambrosio AM, Halsey NA, Peters CJ. 1998. Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group. J. Infect. Dis. 177:277-283. http://dx.doi.org/10.1086/514211.
33. Bradfute S, Stuthman K, Shurtleff A, Bavari S. 2011. A STAT-1 knockout mouse model for Machupo virus pathogenesis. Virol. J. 8:300. http://dx.doi.org/10.1186/1743-422X-8-300.
34. Mcleod CG, Stookey JL, Eddy GA, Scott K. 1976. Pathology of chronic Bolivian hemorrhagic fever in the rhesus monkey. Am. J. Pathol. 84:211-224.
35. Kastello MD, Eddy GA, Kuehne RW. 1976. A rhesus monkey model for the study of Bolivian hemorrhagic fever. J. Infect. Dis. 133:57-62. http://dx.doi.org/10.1093/infdis/133.1.57.
36. McLeod CG, Stookey JL, White JD, Eddy GA, Fry GA. 1978. Pathology of Bolivian hemorrhagic fever in the African green monkey. Am. J. Trop. Med. Hyg. 27:822-826.
37. Kenyon RH, Green DE, Eddy GA, Peters CJ. 1986. Treatment of Junin virus-infected guinea pigs with immune serum: development of late neurological disease. J. Med. Virol. 20:207-218. http://dx.doi.org/10.1002/jmv.1890200303.
38. Kolokoltsova OA, Yun NE, Poussard AL, Smith JK, Smith JN, Salazar M, Walker A, Tseng C-TK, Aronson JF, Paessler S. 2010. Mice lacking alpha/beta and gamma interferon receptors are susceptible to Junin virus infection. J. Virol. 84:13063-13067. http://dx.doi.org/10.1128/JVI.01389-10.
39. Maiztegui JI, Fernandez NJ, de Damilano AJ. 1979. Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet ii:1216-1217.
40. Johnson KM, McCormick JB, Webb PA, Smith ES, Elliott LH, King IJ. 1987. Clinical virology of Lassa fever in hospitalized patients. J. Infect. Dis. 155:456-464. http://dx.doi.org/10.1093/infdis/155.3.456.
41. McCormick JB, Fisher-Hoch SP. 2002. Lassa fever. Curr. Top. Microbiol. Immunol. 262:75-109.
42. Emonet SF, Seregin AV, Yun NE, Poussard AL, Walker AG, de la Torre JC, Paessler S. 2011. Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and life-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease. J. Virol. 85:1473-1483.
43. Bergeroné Chakrabarti AK, Bird BH, Dodd KA, McMullan LK, Spiropoulou CF, Nichol ST, Albariño CG. 2012. Reverse genetics recovery of Lujo Virus and role of virus RNA secondary structures in efficient virus growth. J. Virol. 86:10759-10765. http://dx.doi.org/10.1128/JVI.01144-12.
44. Kranzusch PJ, Schenk AD, Rahmeh AA, Radoshitzky SR, Bavari S, Walz T, Whelan SP. 2010. Assembly of a functional Machupo virus polymerase complex. Proc. Natl. Acad. Sci. U.S.A. 107:20069-20074. http://dx.doi.org/10.1073/pnas.1007152107.
45. Hass M, Westerkofsky M, Müller S, Becker-Ziaja B, Busch C, Günther S. 2006. Mutational analysis of the Lassa virus promoter. J. Virol. 80: 12414-12419. http://dx.doi.org/10.1128/JVI.01374-06.
46. Albariño CG, Bergeroné Erickson BR, Khristova ML, Rollin PE, Nichol ST. 2009. Efficient reverse genetics generation of infectious Junin viruses differing in glycoprotein processing. J. Virol. 83:5606-5614. http://dx.doi.org/10.1128/JVI.00276-09.
47. Cornu TI, de la Torre JC. 2001. RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome. J. Virol. 75:9415-9426. http://dx.doi.org/10.1128/JVI.75.19.9415-9426.2001.
48. Hass M, Golnitz U, Muller S, Becker-Ziaja B, Gunther S. 2004. Replicon system for Lassa virus. J. Virol. 78:13793-13803. http://dx.doi.org/10.1128/JVI.78.24.13793-13803.2004.
49. Lee KJ, Novella IS, Teng MN, Oldstone MB, de La Torre JC. 2000. NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J. Virol. 74:3470-3477. http://dx.doi.org/10.1128/JVI.74.8.3470-3477.2000.
50. Lopez N, Jacamo R, Franze-Fernandez MT. 2001. Transcription and RNA replication of Tacaribe virus genome and antigenome analogs requireNand L proteins: Z protein is an inhibitor of these processes. J. Virol. 75:12241-12251. http://dx.doi.org/10.1128/JVI.75.24.12241-12251.2001.
51. Pinschewer DD, Perez M, de la Torre JC. 2005. Dual role of the lymphocytic choriomeningitis virus intergenic region in transcription termination and virus propagation. J. Virol. 79:4519-4526. http://dx.doi.org/10.1128/JVI.79.7.4519-4526.2005.
52. Lelke M, Brunotte L, Busch C, Gunther S. 2010. An N-terminal region of Lassa virus L protein plays a critical role in transcription but not replication of the virus genome. J. Virol. 84:1934-1944. http://dx.doi.org/10.1128/JVI.01657-09.
53. Muller S, Gunther S. 2007. Broad-spectrum antiviral activity of small interfering RNA targeting the conserved RNA termini of Lassa virus. Antimicrob. Agents Chemother. 51:2215-2218. http://dx.doi.org/10.1128/AAC.01368-06.
54. Lukashevich IS, Patterson J, Carrion R, Moshkoff D, Ticer A, Zapata J, Brasky K, Geiger R, Hubbard GB, Bryant J, Salvato MS. 2005. A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses. J. Virol. 79:13934-13942. http://dx.doi.org/10.1128/JVI.79.22.13934-13942.2005.
55. Webb PA, Justines G, Johnson KM. 1975. Infection of wild and laboratory animals with Machupo and Latino viruses. Bull. World Health Organ. 52:493-499.
56. Eddy G, Scott S, Wagner F, Brand O. 1975. Pathogenesis of Machupo virus infection in primates. Bull. World Health Organ. 52:517-521.
57. Grant A, Seregin A, Huang C, Kolokoltsova O, Brasier A, Peters C, Paessler S. 2012. Junin virus pathogenesis and virus replication. Viruses 4:2317-2339. http://dx.doi.org/10.3390/v4102317.
58. Yun NE, Walker DH. 2012. Pathogenesis of Lassa fever. Viruses 4:2031-2048. http://dx.doi.org/10.3390/v4102031.